GLP-1 / Incretin Research Peptides

Incretin-class peptides are signalling molecules studied in metabolic and endocrinological research. This category groups the incretin receptor agonists in the catalogue – including dual and triple receptor agonists such as Retatrutide and Tirzepatide – characterised in the literature by agonism at the GLP-1 receptor, with some also engaging the GIP and glucagon receptors. Several are investigational molecules that remain the subject of ongoing published research and are not approved medicines. Supplied for laboratory research only, independently tested to 99%+ purity with a batch COA, dispatched from Western Australia.